Blue Flower

Summary of Complaints

Complaints Received Per Day: 0
Complaints Processed Per Day: 0
Complaints Resolved Per Day: 0
Number of Complaints Received: 0
Number of Complaints Resolved: 0
Number of Complaints Outstanding: 0
Number of Complaints with Delayed Resolution: 13
Grievances responded to and/or resolved within the stipulated service standards: 11.8 %
Grievances registered related to delivery of project benefits that are actually addressed: 0 %

The averages are based on 20 days period data.

Complaint Statistics

Complaint Map

Summary Table

Age of Grievances and Complaints
Total<= 7 days<= 14 days<= 21 days<= 28 days<= 56 days<= 84 days>= 85 days
Number 17 0 0 1 0 0 0 16
% 100% 0% 0% 5.9% 0% 0% 0% 94.1%


Within Service StandardTime to Resolve Grievances and Complaints
Total<= 7 days<= 14 days<= 21 days<= 28 days<= 56 days<= 84 days>= 85 daysUnresolvedResolved
Number 17 2 2 0 0 0 0 0 0 14 3
% 100% 11.8% 11.8% 0% 0% 0% 0% 0% 0% 88.2% 11.8%
High Priority 0 0 0 0 0 0 0 0 0 0 0
Medium Priority 3 2 2 0 0 0 0 0 0 0 3
Low Priority 14 0 0 0 0 0 0 0 0 14 0
High Priority 100% 0% 0% 0% 0% 0% 0% 0% 0% 100% 0%
Medium Priority 100% 11.8% 11.8% 0% 0% 0% 0% 0% 0% 88.2% 11.8%
Low Priority 100% 0% 0% 0% 0% 0% 0% 0% 0% 100% 0%
Grievances and Complaints Related to Project Benefits
Number 1 0 0 0 0 0 0 0 0 1 0
% 100% 0 0% 0% 0% 0% 0% 0% 0% 100% 0%
High Priority 0 0 0 0 0 0 0 0 0 0 0
Medium Priority 0 0 0 0 0 0 0 0 0 0 0
Low Priority 1 0 0 0 0 0 0 0 0 1 0
High Priority 100% 0% 0% 0% 0% 0% 0% 0% 0% 100% 0%
Medium Priority 100% 0% 0% 0% 0% 0% 0% 0% 0% 100% 0%
Low Priority 100% 0% 0% 0% 0% 0% 0% 0% 0% 100% 0%
Grievances and Complaints Related to Project Benefits and Related to Females
Number 1 0 0 0 0 0 0 0 0 1 0
% 100% 0 0% 0% 0% 0% 0% 0% 0% 100% 0%
High Priority 0 0 0 0 0 0 0 0 0 0 0
Medium Priority 0 0 0 0 0 0 0 0 0 0 0
Low Priority 1 0 0 0 0 0 0 0 0 1 0
High Priority 100% 0% 0% 0% 0% 0% 0% 0% 0% 100% 0%
Medium Priority 100% 0% 0% 0% 0% 0% 0% 0% 0% 100% 0%
Low Priority 100% 0% 0% 0% 0% 0% 0% 0% 0% 100% 0%
The GCLS was developed with the support of ACP-EU